Bell Investment Advisors’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $13.2K | Buy |
46
+9
| +24% | +$2.59K | ﹤0.01% | 567 |
|
2025
Q1 | $11.4K | Hold |
37
| – | – | ﹤0.01% | 552 |
|
2024
Q4 | $13.1K | Buy |
37
+1
| +3% | +$353 | ﹤0.01% | 506 |
|
2024
Q3 | $12.9K | Hold |
36
| – | – | ﹤0.01% | 525 |
|
2024
Q2 | $11.5K | Buy |
36
+8
| +29% | +$2.55K | ﹤0.01% | 564 |
|
2024
Q1 | $6.43K | Sell |
28
-10
| -26% | -$2.3K | ﹤0.01% | 788 |
|
2023
Q4 | $8.36K | Buy |
38
+8
| +27% | +$1.76K | ﹤0.01% | 630 |
|
2023
Q3 | $6.78K | Buy |
30
+4
| +15% | +$904 | ﹤0.01% | 662 |
|
2023
Q2 | $5.74K | Sell |
26
-12
| -32% | -$2.65K | ﹤0.01% | 745 |
|
2023
Q1 | $8.51K | Buy |
38
+3
| +9% | +$672 | ﹤0.01% | 546 |
|
2022
Q4 | $9.73K | Buy |
35
+2
| +6% | +$556 | ﹤0.01% | 495 |
|
2022
Q3 | $7K | Sell |
33
-3
| -8% | -$636 | ﹤0.01% | 556 |
|
2022
Q2 | $8K | Buy |
+36
| New | +$8K | ﹤0.01% | 525 |
|
2021
Q4 | $5K | Buy |
21
+6
| +40% | +$1.43K | ﹤0.01% | 808 |
|
2021
Q3 | $3K | Buy |
+15
| New | +$3K | ﹤0.01% | 982 |
|